ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 2687

Prevalence of Abortions and Fetal Atrioventricular Block in Patients with Positive ANTI-RO and ANTI-La Antibodies

Isabel Martinez Cordellat1, Francisco Miguel Ortiz-Sanjuán1, Jose Ivorra Cortes1, Luis Gonzalez Puig1, Inmaculada Chalmeta Verdejo1, Irene Calabuig Sais2, Elena Grau Garcia1,3, Carlos Feced Olmos1, Eztizen Labrador Sanchez1, Karla Arevalo Ruales1, Rosa Negueroles Albuixech1, Jorge Fragio Gil1, Jose Luis Valero Sanz1, Cristina Alcañiz Escandell1,3, Carmen Najera Herranz1, Gema Poveda Marin1,3 and Jose Andres Roman Ivorra1,2,3, 1Department of Rheumatology, Hospital Universitario y Politecnico La Fe, Valencia, Spain, 2Universidad Católica de Valencia, Valencia, Spain, 3IIS La Fe, Valencia, Spain

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: Antibodies

Session Information

Date: Tuesday, November 15, 2016

Title: Sjögren's Syndrome - Poster II: Clinical Science

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Anti-SSA/Ro and anti-SSB/La antibodies are present in inflammatory autoimmune disease patient sera, and there are related to different clinical manifestations. It is well known the association between the presence of these antibodies in maternal blood and fetal atrioventricular block. However, there are no much studies about infertility or repeated abortions and anti-SSA/Ro and anti-SSB/La antibodies in broad series. The aim of this study is to characterise a cohort of patients with positive anti-SSA/Ro and/or anti-SSB/La antibodies and to evaluate the prevalence of abortions and neonatal mortality.

Methods:   Observational descriptive study with 162 patients older than 15 years old with pregnancies history and positive anti-SSA/Ro and/or anti-SSB/La antibodies from February 2011 to July 2015. We consider healthy women with pregnancies history and with comparable characteristics as negative control group.  

Results:   We included 162 patients with positive anti-SSA/Ro and/or anti-SSB/La antibodies with a mean age of 50.5±14.2 years old. Main diagnosis were systemic lupus erythematosus (n=85), Sjögren syndrome (n=40), rheumatoid arthritis (n=16), systemic sclerosis (n=6), mixed connective tissue disease (n=3) and other diagnosis (n=12). Lupus anticoagulant was positive in 8 cases and 57 patients showed low complement values. 37% of patients had at least one pregnancy, and the 36.7% aborted during pregnancy. There were no significant differences in the abortion incidence between our cohort of patients and the healthy control group considered. We observed 4 cases of fetal atrioventricular block, all of them with positive anti-SSA/Ro and/or anti-SSB/La antibodies and only in one case also with positive lupus anticoagulant.

Conclusion:   In our series, pregnant women with positive anti-SSA/Ro and/or anti-SSB/La antibodies did not show high prevalence of abortion. However, the positivity of these antibodies was statistically correlated with the presence of fetal atrioventricular block.


Disclosure: I. Martinez Cordellat, None; F. M. Ortiz-Sanjuán, None; J. Ivorra Cortes, None; L. Gonzalez Puig, None; I. Chalmeta Verdejo, None; I. Calabuig Sais, None; E. Grau Garcia, None; C. Feced Olmos, None; E. Labrador Sanchez, None; K. Arevalo Ruales, None; R. Negueroles Albuixech, None; J. Fragio Gil, None; J. L. Valero Sanz, None; C. Alcañiz Escandell, None; C. Najera Herranz, None; G. Poveda Marin, None; J. A. Roman Ivorra, None.

To cite this abstract in AMA style:

Martinez Cordellat I, Ortiz-Sanjuán FM, Ivorra Cortes J, Gonzalez Puig L, Chalmeta Verdejo I, Calabuig Sais I, Grau Garcia E, Feced Olmos C, Labrador Sanchez E, Arevalo Ruales K, Negueroles Albuixech R, Fragio Gil J, Valero Sanz JL, Alcañiz Escandell C, Najera Herranz C, Poveda Marin G, Roman Ivorra JA. Prevalence of Abortions and Fetal Atrioventricular Block in Patients with Positive ANTI-RO and ANTI-La Antibodies [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-abortions-and-fetal-atrioventricular-block-in-patients-with-positive-anti-ro-and-anti-la-antibodies/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-abortions-and-fetal-atrioventricular-block-in-patients-with-positive-anti-ro-and-anti-la-antibodies/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology